期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | Molecular Cancer LetPub Score 8.5
52 ratings
Rate
Reputation 8.6 Influence 8.3 Speed 8.7 | ||||||||||||||||||||||||
期刊簡稱 | MOL CANCER | ||||||||||||||||||||||||
ISSN | 1476-4598 | ||||||||||||||||||||||||
h-index | 103 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://molecular-cancer.biomedcentral.com | ||||||||||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/12943/3 | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||
每年文章數 | 165每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
OA Related Info![]() | APC: Yes( EUR3990; USD4890; GBP3490; ) APC waiver:Check Notes Other charges: No Keywords: oncology、tumour biology、cancer antigens Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Molecular Cancer] 的評論 | 撰寫評論 |
作者: 凌霄子芸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-17 11:53:58 評論於 After my technical check, it is peer review, but the main interface only shows that my technical check has passed. Does this mean it has been submitted for review? ![]() ![]() |
作者: 仲夏和平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-15 10:20:59 評論於 Review speed: 3.0 Research focus: cancer Experience sharing: Submitted before Christmas, still in peer review after three months, indicating that The editors' decision can take several weeks as they may consult peer reviewers ![]() ![]() |
作者: 南烟小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 12:29:00 評論於 There shouldn't be too much personal relationships mentioned in the article, it's all talk and no substance ![]() ![]() |
作者: Lucy Larkin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-06 22:51:08 評論於 Review speed: 2.0 | Submission hit rate: 5.0 Research focus: Tumors; Sharing experience in tumor chemotherapy: It is already quite difficult to submit a molecular cancer research series article with a hard submission now. Of course, there are some low-level articles related to non-coding RNA in the journal. Although journals like Big CDD, Nature, Journal of Hepatology, Cancer Research, Advanced Science, etc., sometimes publish related articles, the quality of the articles is not much different. In this regard, I hope that the Molecular Cancer journal can make improvements ![]() ![]() |
作者: 仲夏和平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-25 20:39:12 評論於 I have also been peer reviewing for two months, and I have received one reviewer report ![]() ![]() |
作者: 晔晔公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-02 08:40:58 評論於 How do I know if I have invited reviewers? Did you send an email notification? ![]() ![]() |
作者: 晔晔公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-01 23:01:45 評論於 How long have you been waiting? When did you apply? ![]() ![]() |
作者: 晔晔公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-30 14:22:43 評論於 Is this technology peer reviewed directly after verification? But the main interface is editor-appointed. Is this how it goes for all the experts? ![]() ![]() |
作者: 飞月远航 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-30 11:39:25 評論於 I am the same way ![]() ![]() |
作者: Joanne Chesterton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-30 08:00:59 評論於 I am two months old ![]() ![]() |
作者: 金山智明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 17:16:11 評論於 How long did it take for your manuscript to reach the reviewers in the end? I've been unable to find a reviewer for mine ![]() ![]() |
作者: 金山智明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-25 15:22:31 評論於 When can we expect to hear back from you? ![]() ![]() |
作者: 重阳芳泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-17 17:29:47 評論於 Review speed: 2.0 | Submission acceptance rate: 25.0 Experience sharing: Submitted a comprehensive review, was rejected by Nature Cancer, two months for minor revisions ![]() ![]() |
作者: 崇学小姐姐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-12 09:21:22 評論於 This magazine is indeed getting more and more difficult ![]() ![]() |
作者: Antony Herty 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-11 10:44:22 評論於 This magazine is becoming more and more serious now ![]() ![]() |
作者: Joanne Chesterton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 18:48:02 評論於 I have been in this state for a month ![]() ![]() |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 15:40:44 評論於 Instant Rejection ![]() ![]() |
作者: Joanne Chesterton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-10 11:59:08 評論於 I have one class per month ![]() ![]() |
作者: 一吃就胖小红霞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 08:35:28 評論於 Remember to come back and update your status ![]() ![]() |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-09 08:04:54 評論於 Made some changes and reuploaded in return ![]() ![]() |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-02 09:32:35 評論於 Research focus: Tumor Biology Experience sharing: I submitted a review article to a journal with an impact factor of 1.7, let's see how long it takes to get rejected ![]() ![]() |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-01 20:52:15 評論於 What happened next? ![]() ![]() |
作者: Joanne Chesterton 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-30 16:45:34 評論於 The editor has been appointed for a month now. Have you ever encountered this situation, where there are too many articles to handle? ![]() ![]() |
作者: 魔都吉星 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-28 08:40:57 評論於 I went through 3 rounds of peer review, inviting a total of 5 reviewers. The number of invitations for each round is displayed before review invited. Once the reviewers agree, it shows as agreed. After the review is completed, it prompts for received reports, and finally, a decision is made. Now we also require uploading of raw data, and I have replied to over 100 comments, which is indeed much more rigorous than before ![]() ![]() |
作者: 金山智明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-26 16:59:45 評論於 Hello, could you please share the specific changes in each step? Right now, I see "4 reviewers invited" ![]() ![]() |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us